Pacira BioSciences to Participate in Fireside Chat at the 21st Annual Needham Virtual Healthcare Conference

Rhea-AI Summary

Pacira BioSciences, Inc. (NASDAQ: PCRX) will participate in an analyst-led fireside chat at the 21st Annual Needham Virtual Healthcare Conference on April 12, 2022, at 8:45 AM ET. Interested parties can access the live audio on the company’s events page. A replay will be available for two weeks post-event.

Pacira focuses on providing non-opioid treatment options for patients, with commercial-stage products like EXPAREL®, ZILRETTA®, and ioveraº®. The company aims to redefine opioid use and addresses conditions involving the sympathetic nervous system.

TAMPA, Fla., April 05, 2022 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX) today announced that it will participate in an analyst-led fireside chat at the 21^st Annual Needham Virtual Healthcare Conference at 8:45 AM ET on Tuesday, April 12, 2022. Live audio of the event can be accessed by visiting the “Events” page of the company’s website at investor.pacira.com. A replay of the webcast will also be available for two weeks following the event.

About Pacira         

Pacira BioSciences, Inc. (Nasdaq: PCRX) is committed to providing a non-opioid option to as many patients as possible to redefine the role of opioids as rescue therapy only. The company is also developing innovative interventions to address debilitating conditions involving the sympathetic nervous system, such as cardiac electrical storm, chronic pain, and spasticity. Pacira has three commercial-stage non-opioid treatments: EXPAREL^® (bupivacaine liposome injectable suspension), a long-acting, local analgesia currently approved for postsurgical pain management; ZILRETTA^® (triamcinolone acetonide extended-release injectable suspension), an extended-release, intra-articular, injection indicated for the management of osteoarthritis knee pain; and ioveraº^®, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. To learn more about Pacira, including the corporate mission to reduce overreliance on opioids, visit www.pacira.com.

FAQ

When is Pacira's participation in the Needham Virtual Healthcare Conference?

Pacira BioSciences, Inc. will participate on April 12, 2022, at 8:45 AM ET.

How can I access the live audio of Pacira's conference presentation?

The live audio can be accessed on Pacira's events page on their website.

What is the primary focus of Pacira BioSciences, Inc.?

Pacira is focused on providing non-opioid treatment options and addressing debilitating conditions related to the sympathetic nervous system.

What products does Pacira have on the market?

Pacira's commercial-stage products include EXPAREL®, ZILRETTA®, and ioveraº®.

Is there a replay available for Pacira's conference presentation?

Yes, a replay will be available for two weeks following the event.